Gabriel Vorobiof, MD

Gabriel Vorobiof, MD

Cardiology
Primary Location
UCLA General Cardiology Med Plaza 100 Ste. 545
100 Medical Plaza
545
Los Angeles, California 90095
Phone
Fax
310-825-9012

About

Preferred Name: Gabe Vorobiof

Education

Fellowship

University of Rochester Medical Center, 2007
Brigham and Women's Hospital, 2008

Residency

St. Luke's - Roosevelt Hospital Center, 2004
Groote Schuur Hospital, 1999

Internship

Maimonides Medical Center, 2002
Baragwanath Hospital, 1998

Degree

University of Witwatersrand Medical School, MBBCh, 1997

Locations

UCLA General Cardiology Med Plaza 100 Ste. 545

Hospital Affiliations

Ronald Reagan UCLA Medical Center

Videos

"What preoperative evaluations are required before aortic surgery?" | Aortic Surgery
"What cardiac conditions predispose to the development of aortic disorders?" | Aortic Disorders
"What is the role of medical management in patients with acute aortic syndrome?" | Aortic Disorders

Research

Interests

  • Cardiovascular Imaging
  • Echocardiography
  • Nuclear Cardiology
  • Cardiac Magnetic Resonance
  • Cardiac Computed Tomography

Publications

Link to Dr. Vorobiof's PubMed publications

  1. Vorobiof DA, Sitas F, Vorobiof G. Breast cancer incidence in South Africa. J Clin Oncol. 2001;19(18 Suppl):125S-127S.
  2. Vorobiof G, Hariparsad G, Freinkel W, Said H, Vorobiof DA. Primary osteosarcoma of the breast: a case report. Breast J. 2003;9(3):231-3.
  3. Vorobiof G, Blaxall BC, Bisognano JD. The future of endothelin-receptor antagonism as treatment for systemic hypertension. Curr Hypertens Rep. 2006;8(1):35-44.
  4. Hall B, Jeevanantham V, Simon R, Filippone J, Vorobiof G, Daubert J. Variation in left atrial transmural wall thickness at sites commonly targeted for ablation of atrial fibrillation. J Interv Card Electrophysiol. 2006;17(2):127-32.
  5. Vorobiof G, Goldenberg I, Moss AJ, Zareba W, McNitt S. Effectiveness of the implantable cardioverter defibrillator in blacks versus whites (from MADIT-II). Am J Cardiol. 2006;98(10):1383-6.
  6. Vorobiof G, Minor S, Aktas MK, McNitt S, Rocco TA, Hall B, Huang DT, Wyse DG, Waldo AL, Daubert JP. Analysis of Outcomes Based on Left Ventricular Ejection Fraction in the AFFIRM Study. American Journal of Cardiology. 2008;(In Press).
  7. Vorobiof G, Filippone JD, Kwong T, Pomerantz RM. Comparison of a Novel, Second Generation TnI Assay with TnT in Patients presenting to the Emergency Room with Suspected Acute Coronary Syndrome. Heart. 2008;(In Press).
  8. Vorobiof G, Aktas MK, Minor S, Ling FS. In Vivo Virtual-Histology Intravascular Ultrasound Characteristics in Patients with Acute ST-Elevation Myocardial Infarction and Stable Coronary Artery Disease. American Journal of Cardiology. 2008;(In Press).
  9. Casey L; Nwakanma F; Vorobiof G; Dunaevsky O; Smrcka AV; Blaxall BC. Small molecule disruption of G beta gamma signaling inhibits the progression of heart failure. Circ Res. 2010 Aug 20;107(4):532-9.
  10. Vorobiof G, Kroening D, Hall B, Brugada R, Huang D. Brugada Syndrome with Marked Conduction Disease - Dual Implications of a Novel SCN5A Mutation. Pacing & Clinical Electrophysiology. 2008;31(5):630-4.
  11. Rybicki FJ, Otero HJ, Steigner ML, Vorobiof G, Nallamshetty L, Mitsouras D, Ersoy H, Mather RT, Judy PF, Cai T, Coyner K, Schultz K, Whitmore AG, Di Carli MF. Initial evaluation of coronary images from 320-detector row computed tomography. The International Journal of Cardiovascular Imaging. 2008;24(5):535-46.
  12. Kwong RY, Sattar H, Wu H, Vorobiof G, Gandla V, Steel K, Siu S, Brown KA. Incidence and prognostic implication of unrecognized myocardial scar characterized by cardiac magnetic resonance in diabetic patients without clinical evidence of myocardial infarction. Circulation. 2008;118(10):1011-20.
  13. Odigie E, Okon E, Dodson J, Vorobiof G. Stress-induced Cardiomyopathy Complicating Severe Babesiosis. Cardiol J. 2011;18(1):83-6.
  14. Vorobiof G, Ellestad M. Lead aVR: Dead or Simply Forgotten? JACC Cardiovasc Imaging. 2011 Feb;4(2):187-90.
  15. Vorobiof G, Chandrashekhar Y, Narula J. Intermediate lesions: Retrieving black from shades of gray. JACC Cardiovasc Interv. 2011 Feb;4(2):209-12.
  16. Vorobiof G, Achenbach S, Narula J. Strategies for Radiation Dose Reduction in Cardiac Computed Tomography. North American Cardiology Clinics Imaging, 2011 (Accepted)
  17. Narula J, Suh W, Vorobiof G, King S, et al. Imaging Vulnerable Plaque: Predicting Which Plaques will Pop. Lancet 2011 (In submission)
  18. Saremi F, Vorobiof G. Aberrant Penetrating Posterior Descending Artery From Proximal Right Coronary Artery. Clinical Anatomy 2011 (Accepted).
  19. Suh WM, Berdjis F, Rizi HR, Vorobiof G. Multimodality evaluation and transcatheter closure of a muscular ventricular septal defect. J Am Coll Cardiol. 2011 Nov 1;58(19):e35. 20. Saremi F, Vorobiof G. Coronary Artery Ostial Atresia: Diagnosis and Evaluation of the Conotruncal Anastomotic Collateral Rings Using MDCT. JACC Imaging 2011 (Accepted)
  20. Barseghian A, Bethencourt DM, Vorobiof G. Dual anterior and posterior mitral valve clefts evaluated by 3-dimensional echocardiography with robot-assisted surgical correction. J Thorac Cardiovasc Surg. 2012 Feb;143(2):503-4.

Awards

  • 2007 Star Award of Excellence, U. Of Rochester School Of Medicine And Dentistry
  • 2007 ACCF Bristol-Myers Squibb Research Award, American College of Cardiology Foundation
  • 2006-2007 Chief Fellow in Cardiovascular Medicine, U. Of Rochester School Of Medicine And Dentistry
  • 2006 Winner, Sable Foundation Grant for Cardiovascular Research, U. Of Rochester School Of Medicine And Dentistry
  • 2006 Scripps Clinic Interventional Cardiology Fellowship Award, Scripps Clinic, Sand Diego, CA
  • 2006 Finalist, Northwestern University Young Cardiovascular Forum, Northwestern U. Medical School
  • 2006 Finalist, Duke Clinical Research Institute Abstract Contest, Duke University
  • 2005 Second place, H.J.C. Swan Memorial Prize for Medical Writing, Cardiology Journal, Basel, Switzerland
  • 2004 Henry I. Russek Award, New York Cardiovascular Symposium, American College of Cardiology